Royalty Pharma Change in Accounts Receivable 2019-2025 | RPRX
Royalty Pharma change in accounts receivable for the twelve months ending March 31, 2025 was $-0.005B, a 252650% decline year-over-year.
- Royalty Pharma annual change in accounts receivable for 2024 was $-0.005B, a 199.21% increase from 2023.
- Royalty Pharma annual change in accounts receivable for 2023 was $-0.002B, a 67.94% decline from 2022.
- Royalty Pharma annual change in accounts receivable for 2022 was $-0.005B, a 83.72% decline from 2021.